FunHoMic is a Marie Curie Innovative Training Network that will train 13 Early Stage Researchers and decipher the fungus-host-microbiota interplay to improve the management of fungal infections. FunHoMIc is coordinated by Christophe d’Enfert at Institut Pasteur and brings together 7 academic partners and 3 SMEs.
Fungal infections have a major impact on human health, infecting about 2 billion people and killing more people each year than malaria or breast cancer. In particular, Candida species impose a high clinical and economic burden upon the European population. They frequently cause fatal hospital-acquired bloodstream infections. They also cause oral thrush and vaginitis. Most women have suffered an episode of vulvovaginal candidiasis, with ~8% enduring recurrent infections. The initiation and severity of a Candida infection depends on an intricate interplay between the infecting fungal strain and the individual’s immune status and microbiota, all of which can display significant variability. Therefore, for the first time, FunHoMic integrates experts in fungal pathogenesis, immunology, microbial ecology and ‘omics technologies to train 13 Early Stage Researchers (ESRs) who will define and exploit this Fungal-Host-Microbiota interplay to identify novel biomarkers (fungal or host genetic polymorphisms, microbiota profiles, metabolites or immune markers) for the stratification of a patient’s risk of serious fungal infection. This will pave the way for precision medicine in patient management through preventive or therapeutic interventions using antifungals, immune modulators or Live Biotherapeutic Products (LBPs). FunHoMic ESRs will gain broad interdisciplinary skills plus a translational mindset through our integrated, inter-sectoral training program. This will allow Europe to remain at the forefront of translational research in the field of medical mycology. To achieve this vision FunHoMic unites academic partners from France, Germany, The Netherlands, Switzerland, Spain and UK, a French Technology Research Institute with cutting-edge ‘omics technology platforms and three SMEs from The Netherlands, Belgium and France that bring unrivalled organ-on-chip and gastro-intestinal tract simulation technologies and expertise in the development and exploitation of innovative LBPs.
Institut Pasteur, Paris, France – Christophe d’Enfert (coordinator) and Marie Elisabeth Bougnoux
Hans Knoell Institute, Jena, Germany – Bernhard Hube and Ilse Jacobsen
Radboud University Medical Center, Nijmegen, The Netherlands – Mihai Netea
Zürich University, Zürich, Switzerland – Salomé LeibunGut-Landmann
Vall d’Hebron Research Institute, Barcelona, Spain – Chays Manichanh
University of Aberdeen, Aberdeen, UK – Alan Walker, Carol Munro, Al Brown
BIOASTER, Lyon, France – Vincent Thomas, Frédéric Bequet
Mimetas, Leiden, The Netherlands – Henriette Lang, Remko van Vught
ProDigest, Gent, Belgium – Massimo Marzorati
biose, Aurilllac, France – Adrien Nivoliez
For more information about ESR positions: contact firstname.lastname@example.org